This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-02-09 CDAMG Conference Call"
Jump to navigation
Jump to search
Lisa Nelson (talk | contribs) |
Lisa Nelson (talk | contribs) |
||
| Line 82: | Line 82: | ||
***Any updates as a result of activity at the WGM? | ***Any updates as a result of activity at the WGM? | ||
***Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT. | ***Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT. | ||
| + | ***Can we add: Threat and Opportunity - Trend toward mapping/developing FHIR and CDA interchange guidance simultaneously. Opportunity is to coordinate these efforts for consistency. Threat is decreased interoperability if not many simultaneous efforts produce divergent in inconsistent solutions | ||
**Asset List - Status, and ongoing management. | **Asset List - Status, and ongoing management. | ||
***Discuss Status/Development toward CDA Template Interchage Format | ***Discuss Status/Development toward CDA Template Interchage Format | ||
Revision as of 15:47, 9 February 2018
back to CDA Management Group main page
| HL7 CDAMG Minutes Location: Pelican - Riverside Bldg. |
Date: 2018-02-09 Time: 2:00 PM (ET) | ||
| Facilitator | Brett | Note taker(s) | Lisa |
| Attendee | Name
| ||
| George Dixon | |||
| Jean Duteau | |||
| Rick Geimer | |||
| Kai Heitmann | |||
| Brett Marquard | |||
| Linda Michaelsen | |||
| Dale Nelson | |||
| Lisa Nelson | |||
| Andrew Statler | |||
| Quorum: Chair +3 | |||
Agenda & Minutes
- Welcome
- Agenda review
- Approve Minutes of 2018-01-29_CDAMG_WGM
- Review items
- Discussion Topics
- SWOT
- Reviewed the SWOT
- Any updates as a result of activity at the WGM?
- Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
- Can we add: Threat and Opportunity - Trend toward mapping/developing FHIR and CDA interchange guidance simultaneously. Opportunity is to coordinate these efforts for consistency. Threat is decreased interoperability if not many simultaneous efforts produce divergent in inconsistent solutions
- Asset List - Status, and ongoing management.
- Discuss Status/Development toward CDA Template Interchage Format
- Discuss Status of CDA Template Registry
- What actions remain to be completed?
- Review progress on CMG Wiki changes - what's left to be completed?
- Discuss need for & Development of overall CDA Product Roadmap
- Roadmap needs to address questions like:
- Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
- Expectation for CDA R2.0 after CDA R2.1 is released?
- What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
- Strategies for aligning C-CDA with FHIR?
- Roadmap needs to address questions like:
- Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
- Review minutes from 2018-01-29.
- Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
- Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
- Discuss C-CDA Value Set Maintenance situation - what role needed from CMG? (Lisa)
- SWOT
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
